Atlas Trials

UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors

Clinical trial NCT06760117 · RECRUITING

Trial details

NCT number
NCT06760117
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric Solid Tumor
Start date
2022-01-01
Primary completion
2025-06-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.